eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
8/2008
vol. 12
 
Share:
Share:
abstract:

Integrin inhibitors in cancer treatment

Janusz Rolski
,
Maciej Niemiec

Współczesna Onkologia (2008) vol. 12; 8 (374–379)
Online publish date: 2008/12/05
View full text Get citation
 
Integrins are the transmembrane proteins involved in intercellular communication and in the contact of cells with extracellular matrix. They are present in healthy and cancer cells as well. They are important in many processes: among other things, thrombosis, angiogenesis and in the metastasis of the neoplastic cells. This article summarizes current knowledge of integrin inhibitors in cancer treatment. All the available studies prove that they have the restrained toxicity and anticancer activity. Introducing them to the standard clinical practice needs further intensive studies.
keywords:

integrins, angiogenesis inhibitors, cell adhesion molecules

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.